Inventor

GIBOT SEBASTIEN

FR8 patents

⚠️ This page may combine multiple inventors who share the name “GIBOT SEBASTIEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV HENRI POINCARE NANCY I

2 patents

US8013116B2Sep 6, 2011

Therapeutic peptides and method

UNIV HENRI POINCARE NANCY I21 citations87

US8021836B2Sep 20, 2011

Method of diagnosing infectious disease by measuring the level of soluble TREM-1 in a sample

UNIV HENRI POINCARE NANCY I26 citations83

GIBOT SEBASTIEN

2 patents

US9815883B2Nov 14, 2017

Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof

GIBOT SEBASTIEN3 citations67

US9255136B2Feb 9, 2016

Inhibiting peptides derived from TREM-like transcript 1 (TLT-1) and uses thereof

GIBOT SEBASTIEN3 citations67

INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)

1 patent

US9657081B2May 23, 2017

Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (TREM-1) TREM-like transcript 1 (TLT-1) for treatment of cardiovascular diseases

INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)4 citations67

FAURE GILBERT

1 patent

US9273111B2Mar 1, 2016

Therapeutic TREM-1 peptides

FAURE GILBERT4 citations64

INOTREM

1 patent

US10948498B2Mar 16, 2021

Methods and kits for predicting the risk of having a cardiovascular disease or event

INOTREM1 citations49

UNIV DE LORRAINE

1 patent

US10603357B2Mar 31, 2020

Therapeutic TREM-1 peptides

UNIV DE LORRAINE0 citations48